论文部分内容阅读
目的:分析博利康尼结合酮替芬药物对小儿咳嗽异形哮喘患者的治疗效果。方法:选取2012年1月-2013年12月紫金县蓝塘中心卫生院收治的小儿咳嗽异性哮喘疾病患者62例作为研究对象,分为观察组与对照组,每组各31例。对照组患者给予氨茶碱药物进行治疗,观察组患者给予博利康尼结合酮替芬药物进行治疗,并对两组患者治疗效果进行对比分析。结果:两组患者给予不同治疗,对照组患者治疗总有效21例,占67.75%,观察组患者治疗总有效30例,占97.77%,两组数据对比显示,观察组治疗效果明显优于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:小儿咳嗽异性哮喘疾病过程中博利康尼药物联合酮替芬药物实施治疗后,可有效提高患者治疗效果,降低病情复发率,还可以缩短患者患病时间,减少疾病症状出现。
OBJECTIVE: To analyze the curative effect of combination of ketoprofen and ketotifen on children with cough-typed asthma. Methods: From January 2012 to December 2013, 62 patients with pediatric cough and asthma inpatients admitted to Lantang Central Hospital of Zijin County were enrolled in this study. The patients were divided into observation group and control group, with 31 cases in each group. Patients in the control group were treated with aminophylline, and patients in the observation group were given combiblocin combined with ketotifen for treatment. The therapeutic effect was compared between the two groups. Results: The two groups of patients given different treatment, the control group, the total effective treatment of 21 cases, accounting for 67.75%, the observation group, the total effective treatment of 30 cases, accounting for 97.77%, two sets of data showed that the observation group was significantly better than the control group , The difference between groups was statistically significant (P <0.05). CONCLUSION: The treatment of patients with cough and allergic asthma with combination therapy of blebidine and ketotifen can effectively improve the treatment effect, reduce the recurrence rate, shorten the time of illness and reduce the symptoms of the disease.